BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10508424)

  • 1. Mechanism by which heparin proteoglycan modulates mast cell chymase activity.
    Pejler G; Sadler JE
    Biochemistry; 1999 Sep; 38(37):12187-95. PubMed ID: 10508424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.
    Pejler G
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):897-903. PubMed ID: 9003378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycationic peptides as inhibitors of mast cell serine proteases.
    Lundequist A; Juliano MA; Juliano L; Pejler G
    Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell chymase in complex with heparin proteoglycan is regulated by protamine.
    Pejler G
    FEBS Lett; 1996 Apr; 383(3):170-4. PubMed ID: 8925890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.
    Pejler G; Söderström K; Karlström A
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):507-13. PubMed ID: 8172612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin is inactivated by mast cell secretory granule chymase.
    Pejler G; Karlström A
    J Biol Chem; 1993 Jun; 268(16):11817-22. PubMed ID: 8505310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity.
    Karlson U; Pejler G; Tomasini-Johansson B; Hellman L
    J Biol Chem; 2003 Oct; 278(41):39625-31. PubMed ID: 12900423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.
    Sayama S; Iozzo RV; Lazarus GS; Schechter NM
    J Biol Chem; 1987 May; 262(14):6808-15. PubMed ID: 3553192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile.
    Karlson U; Pejler G; Froman G; Hellman L
    J Biol Chem; 2002 May; 277(21):18579-85. PubMed ID: 11896050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II generation by mast cell alpha- and beta-chymases.
    Caughey GH; Raymond WW; Wolters PJ
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):245-57. PubMed ID: 10899625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of extravascular coagulation and fibrinolysis by heparin-dependent mast cell chymase.
    Tchougounova E; Pejler G
    FASEB J; 2001 Dec; 15(14):2763-5. PubMed ID: 11687508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase.
    Sommerhoff CP; Ruoss SJ; Caughey GH
    J Immunol; 1992 May; 148(9):2859-66. PubMed ID: 1573274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
    Pemberton AD; Huntley JF; Miller HR
    Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.
    Frank BT; Rossall JC; Caughey GH; Fang KC
    J Immunol; 2001 Feb; 166(4):2783-92. PubMed ID: 11160345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans.
    Matsumoto R; Sali A; Ghildyal N; Karplus M; Stevens RL
    J Biol Chem; 1995 Aug; 270(33):19524-31. PubMed ID: 7642636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.